BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1311894)

  • 1. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
    Takeda R; Yamazaki T; Ito Y; Koshida H; Morise T; Miyamori I; Hashimoto T; Morimoto S
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
    Sundsfjord JA; Marton P; Jorgensen H; Aakvaag A
    J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321
    [No Abstract]   [Full Text] [Related]  

  • 3. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone: review of its physiology and diagnostic aspects of primary aldosteronism.
    Horton R
    Metabolism; 1973 Dec; 22(12):1525-45. PubMed ID: 4357694
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary aldosteronism.
    McGuffin WL; Gunnells JC
    Urol Clin North Am; 1977 Jun; 4(2):227-37. PubMed ID: 331615
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
    Biglieri EG; Kater CE; Arteaga EE
    J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional black adenoma of the adrenal cortex. A rare cause of primary aldosteronism.
    Caplan RH; Virata RL
    Am J Clin Pathol; 1974 Jul; 62(1):97-103. PubMed ID: 4134750
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A; Luetscher JA; Weinberger MH
    Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primay hyperaldosteronism--diagnostic and treatment].
    Potthoff SA; Beuschlein F; Vonend O
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2480-4. PubMed ID: 23168980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone-producing adenoma with prolonged amelioration by dexamethasone.
    Gomi Y; Taniyama M; Ban Y; Takahashi R; Suzuki S; Murai M
    Endocr J; 2001 Jun; 48(3):331-6. PubMed ID: 11523904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A description of a case of Conn's syndrome (author's transl)].
    Martin PL; Dallocchio M; Fourcade JP; Clémenty J; Coqueran J; Choussat A; Bricaud H
    J Radiol Electrol Med Nucl; 1974 May; 55(5):419-22. PubMed ID: 4408421
    [No Abstract]   [Full Text] [Related]  

  • 13. [An observation of Conn's syndrome. Clinical and biological study].
    Tourniaire J; Revol A; Maret G; Blanc-Brunat N
    Rev Fr Endocrinol Clin; 1968; 9(4):333-50. PubMed ID: 4302797
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyolysis due to primary hyperaldosteronism.
    Martínez JJ; Oliveira CL; Meneses AL; Rodríguez SA; Corrales PP; López AH; Romero FB
    Endocrinol Nutr; 2009 Oct; 56(8):431-4. PubMed ID: 19959155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H; Vetter W
    Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable surgical outcomes of aldosterone-producing adenoma based on lateralization by CT imaging and hypokalemia: a non-AVS-based strategy.
    Li H; Liu J; Feng X; Liu L; Wei G; Cao X; Li Y
    Int Urol Nephrol; 2017 Dec; 49(12):2151-2156. PubMed ID: 28918446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
    Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An additional child case of an aldosterone-producing adenoma with an atypical presentation of peripheral paralysis due to hypokalemia.
    Dinleyici EC; Dogruel N; Acikalin MF; Tokar B; Oztelcan B; Ilhan H
    J Endocrinol Invest; 2007 Nov; 30(10):870-2. PubMed ID: 18075291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrinologic and circulatory findings in a case of primary aldosteronism].
    Marsen B; Dissmann T; Oelkers W; Lohmann FW; Molzahn M; Gotzen R
    Dtsch Med Wochenschr; 1971 May; 96(22):951-4. PubMed ID: 5578596
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.
    Hennings J; Andreasson S; Botling J; Hägg A; Sundin A; Hellman P
    Langenbecks Arch Surg; 2010 Feb; 395(2):133-7. PubMed ID: 19418066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.